Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1978 2
1984 2
1985 1
1986 1
1988 1
1989 2
1991 1
1994 1
1995 1
1996 1
1998 2
2000 1
2001 3
2004 2
2005 2
2006 3
2007 1
2008 1
2009 2
2010 1
2011 1
2012 1
2013 4
2014 2
2015 1
2017 1
2018 2
2019 4
2020 2
2021 1
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor"
Page 1
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
Reed DR, Grohar P, Rubin E, Binitie O, Krailo M, Davis J, DuBois SG, Janeway KA. Reed DR, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30583. doi: 10.1002/pbc.30583. Epub 2023 Jul 27. Pediatr Blood Cancer. 2023. PMID: 37501549
The Children's Oncology Group (COG) Bone Tumor Committee is responsible for clinical trials and biological research on localized, metastatic, and recurrent osteosarcoma and Ewing sarcoma (EWS). ...In addition, the Committee has data analyses and …
The Children's Oncology Group (COG) Bone Tumor Committee is responsible for clinical trials and biological research on localiz …
Ewing sarcoma of the adrenal gland: a case report and review of the literature.
Eddaoualline H, Mazouz K, Rafiq B, El Mghari Tabib G, El Ansari N, Belbaraka R, El Omrani A, Khouchani M. Eddaoualline H, et al. J Med Case Rep. 2018 Mar 16;12(1):69. doi: 10.1186/s13256-018-1601-7. J Med Case Rep. 2018. PMID: 29544549 Free PMC article. Review.
BACKGROUND: Ewing sarcoma/primitive neuroectodermal tumor is a family of highly malignant proliferation of neuroectodermal origin, most often skeletal, adrenal localization is extremely rare. ...Management of adrenal Ewing sarco …
BACKGROUND: Ewing sarcoma/primitive neuroectodermal tumor is a family of highly malignant proliferation o …
Irinotecan dose schedule for the treatment of Ewing sarcoma.
Slotkin EK, Meyers PA. Slotkin EK, et al. Pediatr Blood Cancer. 2023 Jan;70(1):e30005. doi: 10.1002/pbc.30005. Epub 2022 Oct 2. Pediatr Blood Cancer. 2023. PMID: 36184748 Free PMC article. Review.
Irinotecan and temozolomide achieve objective responses in patients with Ewing sarcoma that recurs after initial therapy. Optimal dose schedules have not been defined. ...Among 180 patients treated with a 5-day irinotecan schedule, there were 52 responses (29%). In …
Irinotecan and temozolomide achieve objective responses in patients with Ewing sarcoma that recurs after initial therapy. Opti …
Ewing's sarcoma/primitive neuroectodermal tumor arising from the adrenal gland: a case report and literature review.
Sasaki T, Onishi T, Yabana T, Hoshina A. Sasaki T, et al. Tumori. 2013 May-Jun;99(3):e104-6. doi: 10.1177/030089161309900326. Tumori. 2013. PMID: 24158076 Review.
We report a rare case of Ewing's sarcoma (ES)/primitive neuroectodermal tumor (PNET) arising from the adrenal gland. ...Resection of the tumor was performed. We obtained the final diagnosis of ES/PNET by immunohistochemical molecular stud …
We report a rare case of Ewing's sarcoma (ES)/primitive neuroectodermal tumor (PNET) arising from the adr …
Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma.
Brookes MJ, Roundhill EA, Jeys L, Parry M, Burchill SA, Rankin KS. Brookes MJ, et al. Pediatr Blood Cancer. 2022 Dec;69(12):e29959. doi: 10.1002/pbc.29959. Epub 2022 Sep 15. Pediatr Blood Cancer. 2022. PMID: 36106829 Free article.
BACKGROUND: Ewing sarcoma (ES) is the second most common primary bone malignancy, with an urgent need for new treatments. ...The level of MT1-MMP expression at diagnosis may be considered as a prognostic biomarker if validated by retrospective analysis of a larger c …
BACKGROUND: Ewing sarcoma (ES) is the second most common primary bone malignancy, with an urgent need for new treatments. ...T …
Autotransplantation in solid tumors.
Spitzer G. Spitzer G. Blood Rev. 1991 Jun;5(2):105-11. doi: 10.1016/0268-960x(91)90042-b. Blood Rev. 1991. PMID: 1912755 Review.
Studies are described of high-dose therapy in metastatic breast cancer, early stage breast cancer, stage IV neuroblastoma, recurrent or bulky disease testicular cancer and Ewing's sarcoma. The outcome in these subgroups with conventional therapy is described …
Studies are described of high-dose therapy in metastatic breast cancer, early stage breast cancer, stage IV neuroblastoma, recurrent …
Adult Primary Peripheral PNET/Ewing's Sarcoma of the Cervical and Thoracic Spine.
Khwaja R, Mantilla E, Fink K, Pan E. Khwaja R, et al. Anticancer Res. 2019 Aug;39(8):4463-4465. doi: 10.21873/anticanres.13619. Anticancer Res. 2019. PMID: 31366545
This case report describes a patient with a rare occurrence of primary spinal intramedullary Ewing's sarcoma (ES) in the cervical and thoracic spine. The older age of disease occurrence, uncommon location in the cervical and thoracic spine, and EWSR1 gene fusion as …
This case report describes a patient with a rare occurrence of primary spinal intramedullary Ewing's sarcoma (ES) in the cervi …
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.
Ogura K, Elkrief A, Bowman AS, Koche RP, de Stanchina E, Benayed R, Mauguen A, Mattar MS, Khodos I, Meyers PA, Healey JH, Tap WD, Hameed M, Zehir A, Shukla N, Sawyers C, Bose R, Slotkin E, Ladanyi M. Ogura K, et al. JCO Precis Oncol. 2022 Aug;6:e2200048. doi: 10.1200/PO.22.00048. JCO Precis Oncol. 2022. PMID: 35952322 Free PMC article.
PURPOSE: Ewing sarcoma (ES) is a primitive sarcoma defined by EWSR1-ETS fusions as the primary driver alteration. ...ERF alterations were nonoverlapping with STAG2 alterations. In vitro, increased expression of ERF decreased tumor cell growth, c …
PURPOSE: Ewing sarcoma (ES) is a primitive sarcoma defined by EWSR1-ETS fusions as the primary driver alteration …
Autologous bone marrow transplantation in paediatric solid tumours.
Pinkerton R, Philip T, Bouffet E, Lashford L, Kemshead J. Pinkerton R, et al. Clin Haematol. 1986 Feb;15(1):187-203. doi: 10.1016/s0308-2261(86)80011-x. Clin Haematol. 1986. PMID: 3516489 Review.
In other paediatric tumours, the relative rarity and limited indications for ABMT make the evaluation of its role more difficult. Preliminary results in advanced rhabdomyosarcoma and Ewing's sarcoma are none the less encouraging and justify further investigation. .. …
In other paediatric tumours, the relative rarity and limited indications for ABMT make the evaluation of its role more difficult. Preliminar …
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
Qayed M, Cash T, Tighiouart M, MacDonald TJ, Goldsmith KC, Tanos R, Kean L, Watkins B, Suessmuth Y, Wetmore C, Katzenstein HM. Qayed M, et al. Pediatr Blood Cancer. 2020 Apr;67(4):e28134. doi: 10.1002/pbc.28134. Epub 2019 Dec 25. Pediatr Blood Cancer. 2020. PMID: 31876107 Clinical Trial.
BACKGROUND/PURPOSE: To determine the maximum tolerated dose, toxicities, and response of sirolimus combined with oral metronomic therapy in pediatric patients with recurrent and refractory solid and brain tumors. PROCEDURE: Patients younger than 30 years of age with …
BACKGROUND/PURPOSE: To determine the maximum tolerated dose, toxicities, and response of sirolimus combined with oral metronomic therapy in …
54 results